RMTI
Rockwell Medical Inc (RMTI)
Healthcare • NASDAQ • $0.83+6.76%
- Symbol
- RMTI
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $0.83
- Daily Change
- +6.76%
- Market Cap
- $32.91M
- Trailing P/E
- N/A
- Forward P/E
- 11.91
- 52W High
- $2.10
- 52W Low
- $0.74
- Analyst Target
- $3.00
- Dividend Yield
- N/A
- Beta
- 1.66
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a …
Company websiteResearch RMTI on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.